FDA Inspection
Offices for Fertility and Reproductive Medicine, P. C.Offices for Fertility and Reproductive Medicine, P. C. – FDA Inspection, Mar 18, 2016
Record Details
This FDA Inspection record concerns Offices for Fertility and Reproductive Medicine, P. C., with an inspection on March 18, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 18, 2016
- Product Type
- Biologics
View Company Profile
ID · f14c6cf9-e9e5-4a01-9fe2-b3f744ddc751
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 962764
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Offices for Fertility and Reproductive Medicine, P. C.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 25, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 28, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Offices for Fertility and Reproductive Medicine, P. C.
- FDA Inspection 1039314 - 2018-01-31
- FDA Inspection 878286 - 2014-05-12
- FDA Inspection 800591 - 2012-09-25
- FDA Inspection 615020 - 2009-09-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.